VIDASYM
VIDASYM
Industry:
Health Care Medical
Founded:
2002-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.vidasym.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API WordPress Content Delivery Network WordPress 6.4 Jetpack Site Accelerator Jetpack
Similar Organizations
Care Everywhere
Care Everywhere is a software medical device company.
Current Employees Featured
Official Site Inspections
http://www.vidasym.com Semrush global rank: 13.63 M Semrush visits lastest month: 75
- Host name: box5908.bluehost.com
- IP address: 162.241.24.236
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Vidasym"
Home – Vidasym: A Promise of New Medicine
Vidasym is a clinical-stage drug discovery/development company that invents and develops novel drugs for treating serious diseases with significant unmet medical need The initial focus is on …See details»
Corporate – Vidasym: A Promise of New Medicine
Vidasym Founded by Abbott alumni with extensive new drug R&D experience Team has advanced multiple therapeutics into clinical development. Alan Lau, Pharm. D. – Interim CEO. …See details»
VIDASYM, INC. - VentureRadar
Vidasym is biopharma company developing proprietary drugs for treatment of chronic kidney disease and other indications. Vidasym is advancing two programs: 1) a highly differentiated …See details»
Vidasym Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Vidasym. Use the PitchBook Platform to explore the full profile.See details»
Vidasym, Inc Company Profile | Sioux Falls, SD | Competitors ...
Find company research, competitor information, contact details & financial data for Vidasym, Inc of Sioux Falls, SD. Get the latest business insights from Dun & Bradstreet.See details»
Vidasym - Crunchbase Company Profile & Funding
Headquarters Regions Greater Chicago Area,Great Lakes,Midwestern US. Founded Date 2002. Operating Status Active. Company Type For Profit.See details»
Vidasym Company Profile | Management and Employees List
Vidasym is a clinical-stage drug discovery/development company that invents and develops novel drugs for the indications of chronic kidney disease complications and osteoporosis.See details»
Vidasym - Overview, News & Similar companies | ZoomInfo.com
Vidasym contact info: Phone number: (847) 260-8432 Website: www.vidasym.com What does Vidasym do? Vidasym is a clinical-stage drug discovery/development company that invents …See details»
Vidasym: A Promise of New Medicines - Home
Web Hosting by BluehostSee details»
Vidasym Company Profile - Office Locations, Competitors ... - Craft
Vidasym is a clinical-stage drug discovery company that develops medications for treating serious diseases. It provides a range of vitamin D receptor modulators (VDRMs) and phosphate …See details»
Vidasym - Contacts, Employees, Board Members, Advisors & Alumni
Vidasym has 1 current employee profile, Acting CEO Terry Opgenorth. Contacts. Edit Contacts Section. We're working on getting contact data for Vidasym . Find more contact data in …See details»
VS 411 - Vidasym - AdisInsight
Vidasym is developing VS 411, a vitamin D analogue, presumably for the treatment of inflammatory bowel disease or psoriasis. The company has stated that most ofSee details»
Preclinical studies of VS‐505: a non‐absorbable highly ... - Wiley
May 7, 2016 · In this study, we present results from preclinical studies showing that VS-505 is effective at binding phosphate and may have advantages over current on-market phosphate …See details»
Pipeline – Vidasym: A Promise of New Medicine
Vidasym patents cover other compounds (e.g. VS-110 and VS-605) that have properties similar to VS-105 and VS-505. In addition to secondary hyperparathyroidism and hyperphosphatemia …See details»
VS 605 - AdisInsight
Jul 29, 2024 · VS 605, a novel phosphate binder derived from Mg (II) and gum Arabic, is being developed by Vidasym for the treatment of hyperphosphataemia. VS 605 is derived.See details»
VIDASYM, INC. | VentureRadar
Vidasym is biopharma company developing proprietary drugs for treatment of chronic kidney disease and other indications. Vidasym is advancing two programs: 1) a highly differentiated …See details»
Alebund Achieved First Patient Enrolment for AP301 Pivotal Phase …
July 17 2023, Shanghai, China — Alebund Pharmaceuticals (“Alebund” or the “Company”), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of …See details»
Scientific Overview – Vidasym: A Promise of New Medicine
VDRAs such as calcitriol and its pro-drug, 1α-hydroxyvitamin D3 (alfacalcidol), have been used as therapeutic agents for osteoporosis since 1983 in many ex-US countries. It is well documented …See details»
New drug VS-501 for treating hyperphosphatemia in chronic …
Sep 1, 2012 · Vidasym plans to develop VS-501 into a reimbursable prescription new drug to treat CKD. Once developed, such a drug will not only reduce the mortality rate in CKD, but also …See details»
Vidasym, Inc. (Vidasym, Inc.) - 药物管线_专利_临床试验_投融营收_ …
访问超过 200 万项资助和基金信息，以提升您的研究之旅。 深入了解从初创企业到成熟企业的最新公司投资动态。 发掘融资趋势以验证和推进您的投资机会。 了解Vidasym, Inc. (Vidasym, …See details»